LLY
Eli Lilly and Co
Pharmaceuticals
Eli Lilly and Co (LLY) Financials
Annual revenue, profit, EPS and free cash flow for LLY, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $65.2B | — | — | $20.6B | $22.95 | — |
| FY2024 | $45.0B | — | — | $10.6B | $11.71 | — |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.